SCHEMBL7960197

SCHEMBL7960197

COC(=O)c1cccc(C2C=C(c3nc(-c4ccccc4)c(-c4ccccc4)o3)CCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 5/20 0.42
PTGIR P43119 5/20 0.42
PTGER1 P34995 1/20 0.42
KDM4E B2RXH2 5/20 0.41
HTT P42858 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
LMNA P02545 2/20 0.41
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
FABP4 P15090 1/20 0.38
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
PDE5A O76074 1/20 0.37
PTGER3 P43115 1/20 0.36
NR4A2 P43354 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957666 0.90 PTGER4 (0.52) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7961609 0.84 KDM4E (0.42) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7961298 0.83 PTGIR (0.52) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7959297 0.80 PTGER4 (0.44) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7959822 0.73 PTGIR (0.54) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7957987 0.72 PTGIR (0.63) PTGER4PTGIRPTGER1KDM4EHPGD
SCHEMBL7949669 0.71 PTGIR (0.49) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7964171 0.70 PTGIR (0.73) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7960001 0.70 PTGIR (0.78) PTGER4PTGIRPTGER1KDM4EHTT
SCHEMBL7964177 0.69 PTGIR (0.68) PTGER4PTGIRPTGER1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed